UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Mystic Asset Management Inc.

Mystic Asset Management Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 76.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,167 shares of the healthcare conglomerate’s stock after purchasing an additional 507 shares during the quarter. Mystic Asset Management Inc.’s holdings in UnitedHealth Group were worth $590,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. boosted its stake in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Clarkston Capital Partners LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $203,000. Prudent Man Advisors LLC boosted its position in shares of UnitedHealth Group by 28.5% in the 3rd quarter. Prudent Man Advisors LLC now owns 2,963 shares of the healthcare conglomerate’s stock valued at $1,732,000 after purchasing an additional 658 shares during the period. Finally, Aljian Capital Management LLC raised its holdings in UnitedHealth Group by 14.2% during the 3rd quarter. Aljian Capital Management LLC now owns 16,243 shares of the healthcare conglomerate’s stock worth $9,497,000 after buying an additional 2,017 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 2.1 %

UnitedHealth Group stock opened at $499.01 on Tuesday. The firm has a market cap of $456.45 billion, a price-to-earnings ratio of 32.19, a P/E/G ratio of 1.37 and a beta of 0.62. The firm has a fifty day moving average price of $511.11 and a two-hundred day moving average price of $549.15. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.